Latest News

Known for its career-focused education programs, this technical training provider just reported a notable insider sale in recent filings.

Shopify stock is down 25% in 2026, but strong growth, cash flow, and merchant demand keep this Canadian stock worth watching.

The Vanguard S&P 500 Index Fund (TSX:VFV) charges a tax so potent, neither the TFSA nor even the mighty RRSP can neutralize it.

With AI-related stocks trading at all-time highs, it's time to start looking at the less obvious candidates.

These two top growth stocks have years of potential to grow both rapidly and consistently, making them ideal long-term investments.

This monthly-paying TSX stock has a solid history of reliable distributions and offers a well-protected yield of 6.1%.

These two top Canadian dividend stocks are not only trading off their highs, but they also both offer yields of more than 4%.

Want to earn Tax-free monthly income in your TFSA? This TSX royalty stock yields 6.1% with a diversified top-line cash-flow rich model.

The stock market is looking more and more like it's 2000.

The Bank of Canada has maintained interest rate at 2.25% in June. This steady rate has pulled down stocks benefiting from a rate cut.

BCE’s dividend was cut sharply in 2025, but the new payout may now be on firmer ground for long-term income investors.

Explore BCE's recent changes and its impact on dividend growth amid rising AI investments in the telecom sector.

SpaceX's business is attractive, but the stock is expensive.

I get this question at least three times a week. Service scope varies wildly. Inspection fees. Usually one of these things: Order size matters a lot. If yo

As a leader in online surplus asset sales, this e-commerce platform reported a notable insider sale amid strong one-year stock gains.

Constellation Software (TSX:CSU) might be more of a riskier play amid AI disruption, but shares are oversold at this point.

The first step is to fully contribute to your TFSA. The second step is to invest it wisely according to your goals, investment horizon, and risk tolerance.

Anthony Scaramucci said a 25-year-old letter about Warren Buffett changed his perspective on aging and success.

This precision oncology innovator, up nearly 500% in a year, just reported significant insider selling amid ongoing drug development efforts.

The market remains skeptical about Telus, yet the telecom giant is quietly strengthening the areas that could decide where its stock heads over the next three years.

Given its resilient regulated business model, a visible growth pipeline, and a proven ability to increase dividends, Fortis offers excellent buying opportunities in this uncertain economic environment.

I siti scommesse sportive rappresentano oggi uno degli strumenti più utilizzati dagli appassionati di sport che desiderano seguire i propri eventi preferit

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Sector allocations and risk profiles differ sharply between these two small-cap growth funds, shaping their long-term appeal for investors.

Compare sector focus, historical volatility, and income strategies to see which ETF aligns with your investment approach.